Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe W Gray

Showing results (141-150 of 261) with videos related to

Pageof 27
Sort By:
Breast Cancer Research and Treatment|October 28, 2016
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breastMichael J Campbell, Frederick Baehner, Tess O'Meara, et al.
Cancer Research|September 5, 2006
Organic cation transporters are determinants of oxaliplatin cytotoxicityShuzhong Zhang, Katherine S Lovejoy, James E Shima, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|March 19, 2011
Topographic enhancement mapping of the cancer-associated breast stroma using breast MRINima Nabavizadeh, Catherine Klifa, David Newitt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expressionMark D Sternlicht, Alison M Dunning, Dan H Moore, et al.
Nature Medicine|October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Plos One|December 20, 2012
ATM suppresses SATB1-induced malignant progression in breast epithelial cellsEllen Ordinario, Hye-Jung Han, Saori Furuta, et al.
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Genome Biology|November 22, 2007
Analysis of molecular inversion probe performance for allele copy number determinationYuker Wang, Martin Moorhead, George Karlin-Neumann, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Molecular Cancer Research : MCR|August 9, 2011
Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancerSheryl R Krig, Seth Frietze, Catalina Simion, et al.
Pageof 27

Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|October 28, 2016
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breastMichael J Campbell, Frederick Baehner, Tess O'Meara, et al.
Cancer Research|September 5, 2006
Organic cation transporters are determinants of oxaliplatin cytotoxicityShuzhong Zhang, Katherine S Lovejoy, James E Shima, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|March 19, 2011
Topographic enhancement mapping of the cancer-associated breast stroma using breast MRINima Nabavizadeh, Catherine Klifa, David Newitt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expressionMark D Sternlicht, Alison M Dunning, Dan H Moore, et al.
Nature Medicine|October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Plos One|December 20, 2012
ATM suppresses SATB1-induced malignant progression in breast epithelial cellsEllen Ordinario, Hye-Jung Han, Saori Furuta, et al.
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Genome Biology|November 22, 2007
Analysis of molecular inversion probe performance for allele copy number determinationYuker Wang, Martin Moorhead, George Karlin-Neumann, et al.
Genome Medicine|April 28, 2017
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesMumtahena Rahman, Shelley M MacNeil, David F Jenkins, et al.
Molecular Cancer Research : MCR|August 9, 2011
Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancerSheryl R Krig, Seth Frietze, Catalina Simion, et al.
Pageof 27